fda warning letters bpc 157 2023 2025 issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of CDER Warning Letters Jump 50%
CDER Warning Letters Jump 50% in FY 2025 What That Means for Industry Trends In FDA FY2023 Inspection Based Warning Letters FDA Warning Letter Breakdown: Inside a GLP Collapse at a Chinese Testing Facility FDA's Overreach on Compounded Peptides FDA Warning Letter to Great Lakes College of BioethicsWatch
Pay in 4 interest-free payments of $6.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




